The wearable infusion pumps market size has grown strongly in recent years. It will grow from $1.51 billion in 2025 to $1.65 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to rising prevalence of diabetes and chronic diseases, advancement in insulin delivery technology, demand for patient-centric care, expansion of home healthcare, growing awareness of wearable infusion systems.
The wearable infusion pumps market size is expected to see strong growth in the next few years. It will grow to $2.36 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to adoption of AI-based dose optimization, integration with smartphone and cloud platforms, growth in multi-drug delivery applications, demand for compact and portable wearable pumps, increasing telehealth services for chronic care management. Major trends in the forecast period include smart wearable insulin pumps, remote monitoring and telehealth integration, ai-driven dose optimization, multi-drug infusion systems, compact and portable device designs.
The increasing prevalence of chronic diseases is increasingly supporting the expansion of the wearable infusion pump market going forward. Chronic diseases are long-term health conditions that progress slowly and persist for extended periods, often requiring continuous medical care. Major chronic diseases include cancer, heart disease, diabetes, and arthritis. The prevalence of chronic diseases continues to rise due to genetic, environmental, and lifestyle-related factors, including poor diet, physical inactivity, and exposure to harmful substances. Wearable infusion pumps assist chronic disease patients by enabling continuous and precise medication delivery, improving adherence, and optimizing treatment outcomes. For example, in June 2024, according to the National Health Service, a UK-based publicly funded healthcare system, 3,615,330 individuals in England were registered with a GP for non-diabetic hyperglycemia in 2023, reflecting an 18% year-on-year increase. As a result, the growing prevalence of chronic diseases is reinforcing demand for wearable infusion pumps.
Leading companies operating in the wearable infusion pump market are developing advanced products such as tubeless, wearable, and disposable insulin pumps to improve user convenience, treatment adherence, and discreet insulin delivery. Tubeless wearable insulin pumps are small, skin-adhered devices that deliver continuous insulin without external tubing and are replaced after a defined period. For example, in February 2023, GulfDrug LLC, a UAE-based healthcare company, launched EOPatch, a tubeless, wearable, and disposable insulin pump controlled via Android and iOS smartphones using the Narsha app. The device offers up to 84 hours of continuous insulin delivery and integrates diabetes data management into a single smartphone platform.
In June 2023, Lohmann Therapie-Systeme AG (LTS), a Germany-based drug delivery systems company, acquired Sorrel from Eitan Medical for $100 million. Through this acquisition, LTS aims to broaden its drug delivery systems portfolio by integrating Sorrel, a wearable drug delivery platform developed by Eitan Medical. Eitan Medical is an Israel-based company specializing in advanced infusion and drug delivery solutions, including wearable infusion pumps such as patient-controlled epidural analgesia systems, designed to enhance patient care through innovative technology.
Major companies operating in the wearable infusion pumps market are Fresenius SE & Co. KGaA, Medtronic Plc, Medline Industries Inc., Becton Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, Nipro Corporation, ICU Medical Inc., Insulet Corporation, Sorenson Medical, Avanos Medical Inc., Vygon SA, pfm medical GmbH, Eitan Medical, Micrel Medical Devices SA, Zyno Medical LLC, Q-Core Medical Ltd., Epic Medical Solutions, MOOG Inc., Smiths Medical International Ltd.
North America was the largest region in the wearable infusion pump market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the wearable infusion pumps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the wearable infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased the cost of imported electronic components, sensors, batteries, and precision plastics used in wearable infusion pumps, raising overall manufacturing and device prices. These impacts are most significant in electronic ambulatory pumps and insulin pump segments, particularly in Asia-Pacific and Europe where component sourcing is highly globalized. Higher prices have affected affordability for hospitals and home care users, potentially slowing device upgrades. However, tariffs have also encouraged local assembly and component sourcing, strengthening regional manufacturing bases and improving long term supply chain resilience.
The wearable infusion pumps market research report is one of a series of new reports that provides wearable infusion pumps market statistics, including wearable infusion pumps industry global market size, regional shares, competitors with a wearable infusion pumps market share, detailed wearable infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the wearable infusion pumps industry. This wearable infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A wearable infusion pump is a portable medical device designed to deliver controlled doses of medication or fluids over extended periods while being worn on the body, allowing continuous or scheduled infusion with greater convenience for patients.
The main types of wearable infusion pumps include electronic ambulatory infusion pumps, patient-controlled analgesia (PCA) pumps, large-volume pumps, syringe pumps, and others. Electronic ambulatory infusion pumps are portable devices that use electronic control systems to deliver accurate and continuous medication doses over a set period. These pumps are available in disposable and reusable formats and are used in applications such as diabetes management, antibiotic delivery, chemotherapy, pain management, Parkinson’s disease treatment, and others.
The wearable infusion pump market consists of sales of infusion sets, reservoirs, and adhesive patches. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The wearable infusion pumps market size is expected to see strong growth in the next few years. It will grow to $2.36 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to adoption of AI-based dose optimization, integration with smartphone and cloud platforms, growth in multi-drug delivery applications, demand for compact and portable wearable pumps, increasing telehealth services for chronic care management. Major trends in the forecast period include smart wearable insulin pumps, remote monitoring and telehealth integration, ai-driven dose optimization, multi-drug infusion systems, compact and portable device designs.
The increasing prevalence of chronic diseases is increasingly supporting the expansion of the wearable infusion pump market going forward. Chronic diseases are long-term health conditions that progress slowly and persist for extended periods, often requiring continuous medical care. Major chronic diseases include cancer, heart disease, diabetes, and arthritis. The prevalence of chronic diseases continues to rise due to genetic, environmental, and lifestyle-related factors, including poor diet, physical inactivity, and exposure to harmful substances. Wearable infusion pumps assist chronic disease patients by enabling continuous and precise medication delivery, improving adherence, and optimizing treatment outcomes. For example, in June 2024, according to the National Health Service, a UK-based publicly funded healthcare system, 3,615,330 individuals in England were registered with a GP for non-diabetic hyperglycemia in 2023, reflecting an 18% year-on-year increase. As a result, the growing prevalence of chronic diseases is reinforcing demand for wearable infusion pumps.
Leading companies operating in the wearable infusion pump market are developing advanced products such as tubeless, wearable, and disposable insulin pumps to improve user convenience, treatment adherence, and discreet insulin delivery. Tubeless wearable insulin pumps are small, skin-adhered devices that deliver continuous insulin without external tubing and are replaced after a defined period. For example, in February 2023, GulfDrug LLC, a UAE-based healthcare company, launched EOPatch, a tubeless, wearable, and disposable insulin pump controlled via Android and iOS smartphones using the Narsha app. The device offers up to 84 hours of continuous insulin delivery and integrates diabetes data management into a single smartphone platform.
In June 2023, Lohmann Therapie-Systeme AG (LTS), a Germany-based drug delivery systems company, acquired Sorrel from Eitan Medical for $100 million. Through this acquisition, LTS aims to broaden its drug delivery systems portfolio by integrating Sorrel, a wearable drug delivery platform developed by Eitan Medical. Eitan Medical is an Israel-based company specializing in advanced infusion and drug delivery solutions, including wearable infusion pumps such as patient-controlled epidural analgesia systems, designed to enhance patient care through innovative technology.
Major companies operating in the wearable infusion pumps market are Fresenius SE & Co. KGaA, Medtronic Plc, Medline Industries Inc., Becton Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, Nipro Corporation, ICU Medical Inc., Insulet Corporation, Sorenson Medical, Avanos Medical Inc., Vygon SA, pfm medical GmbH, Eitan Medical, Micrel Medical Devices SA, Zyno Medical LLC, Q-Core Medical Ltd., Epic Medical Solutions, MOOG Inc., Smiths Medical International Ltd.
North America was the largest region in the wearable infusion pump market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the wearable infusion pumps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the wearable infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased the cost of imported electronic components, sensors, batteries, and precision plastics used in wearable infusion pumps, raising overall manufacturing and device prices. These impacts are most significant in electronic ambulatory pumps and insulin pump segments, particularly in Asia-Pacific and Europe where component sourcing is highly globalized. Higher prices have affected affordability for hospitals and home care users, potentially slowing device upgrades. However, tariffs have also encouraged local assembly and component sourcing, strengthening regional manufacturing bases and improving long term supply chain resilience.
The wearable infusion pumps market research report is one of a series of new reports that provides wearable infusion pumps market statistics, including wearable infusion pumps industry global market size, regional shares, competitors with a wearable infusion pumps market share, detailed wearable infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the wearable infusion pumps industry. This wearable infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A wearable infusion pump is a portable medical device designed to deliver controlled doses of medication or fluids over extended periods while being worn on the body, allowing continuous or scheduled infusion with greater convenience for patients.
The main types of wearable infusion pumps include electronic ambulatory infusion pumps, patient-controlled analgesia (PCA) pumps, large-volume pumps, syringe pumps, and others. Electronic ambulatory infusion pumps are portable devices that use electronic control systems to deliver accurate and continuous medication doses over a set period. These pumps are available in disposable and reusable formats and are used in applications such as diabetes management, antibiotic delivery, chemotherapy, pain management, Parkinson’s disease treatment, and others.
The wearable infusion pump market consists of sales of infusion sets, reservoirs, and adhesive patches. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Wearable Infusion Pumps Market Characteristics
3. Wearable Infusion Pumps Market Supply Chain Analysis
4. Global Wearable Infusion Pumps Market Trends and Strategies
5. Wearable Infusion Pumps Market Analysis of End Use Industries
7. Global Wearable Infusion Pumps Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Wearable Infusion Pumps Total Addressable Market (TAM) Analysis for the Market
9. Wearable Infusion Pumps Market Segmentation
10. Wearable Infusion Pumps Market Regional and Country Analysis
11. Asia-Pacific Wearable Infusion Pumps Market
12. China Wearable Infusion Pumps Market
13. India Wearable Infusion Pumps Market
14. Japan Wearable Infusion Pumps Market
15. Australia Wearable Infusion Pumps Market
16. Indonesia Wearable Infusion Pumps Market
17. South Korea Wearable Infusion Pumps Market
18. Taiwan Wearable Infusion Pumps Market
19. South East Asia Wearable Infusion Pumps Market
20. Western Europe Wearable Infusion Pumps Market
21. UK Wearable Infusion Pumps Market
22. Germany Wearable Infusion Pumps Market
23. France Wearable Infusion Pumps Market
24. Italy Wearable Infusion Pumps Market
25. Spain Wearable Infusion Pumps Market
26. Eastern Europe Wearable Infusion Pumps Market
27. Russia Wearable Infusion Pumps Market
28. North America Wearable Infusion Pumps Market
29. USA Wearable Infusion Pumps Market
30. Canada Wearable Infusion Pumps Market
31. South America Wearable Infusion Pumps Market
32. Brazil Wearable Infusion Pumps Market
33. Middle East Wearable Infusion Pumps Market
34. Africa Wearable Infusion Pumps Market
36. Wearable Infusion Pumps Market Competitive Landscape and Company Profiles
37. Wearable Infusion Pumps Market Other Major and Innovative Companies
40. Wearable Infusion Pumps Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Wearable Infusion Pumps Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses wearable infusion pumps market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for wearable infusion pumps? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The wearable infusion pumps market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Electronic Ambulatory Infusion Pumps; Patient-Controlled Analgesia (PCA) Pumps; Large Volume Pumps; Syringe Pumps; Other Types2) By Usage: Disposable; Reusable
3) By Application: Diabetes; Antibiotic Infusion; Chemotherapy; Pain Management; Parkinson's Disease; Other Applications
Subsegments:
1) By Electronic Ambulatory Infusion Pumps: Portable Infusion Pumps; Implantable Infusion Pumps2) By Patient-Controlled Analgesia (PCA) Pumps: Continuous PCA Pumps; Demand PCA Pumps
3) By Large Volume Pumps: Volumetric Pumps; Gravity Pumps
4) By Syringe Pumps: Infusion Syringe Pumps; Ambulatory Syringe Pumps
5) By Other Types: Insulin Pumps; Chemotherapy Pumps
Companies Mentioned: Fresenius SE & Co. KGaA; Medtronic Plc; Medline Industries Inc.; Becton Dickinson and Company; Baxter International Inc.; B. Braun Melsungen AG; Nipro Corporation; ICU Medical Inc.; Insulet Corporation; Sorenson Medical; Avanos Medical Inc.; Vygon SA; pfm medical GmbH; Eitan Medical; Micrel Medical Devices SA; Zyno Medical LLC; Q-Core Medical Ltd.; Epic Medical Solutions; MOOG Inc.; Smiths Medical International Ltd
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Wearable Infusion Pumps market report include:- Fresenius SE & Co. KGaA
- Medtronic Plc
- Medline Industries Inc.
- Becton Dickinson and Company
- Baxter International Inc.
- B. Braun Melsungen AG
- Nipro Corporation
- ICU Medical Inc.
- Insulet Corporation
- Sorenson Medical
- Avanos Medical Inc.
- Vygon SA
- pfm medical GmbH
- Eitan Medical
- Micrel Medical Devices SA
- Zyno Medical LLC
- Q-Core Medical Ltd.
- Epic Medical Solutions
- MOOG Inc.
- Smiths Medical International Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.65 Billion |
| Forecasted Market Value ( USD | $ 2.36 Billion |
| Compound Annual Growth Rate | 9.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
